Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 23:10:249.
doi: 10.1186/1471-2334-10-249.

Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women

Affiliations

Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women

Jeffrey Parsonnet et al. BMC Infect Dis. .

Abstract

Background: Menstrual Toxic Shock Syndrome (mTSS) is thought to be associated with the vaginal colonization with specific strains of Staphylococcus aureus TSST-1 in women who lack sufficient antibody titers to this toxin. There are no published studies that examine the seroconversion in women with various colonization patterns of this organism. Thus, the aim of this study was to evaluate the persistence of Staphylococcus aureus colonization at three body sites (vagina, nares, and anus) and serum antibody to toxic shock syndrome toxin-producing Staphylococcus aureus among a small group of healthy, menstruating women evaluated previously in a larger study.

Methods: One year after the completion of that study, 311 subjects were recalled into 5 groups. Four samples were obtained from each participant at several visits over an additional 6-11 month period: 1) an anterior nares swab; 2) an anal swab; 3) a vagina swab; and 4) a blood sample. Gram stain, a catalase test, and a rapid S. aureus-specific latex agglutination test were performed to phenotypically identify S. aureus from sample swabs. A competitive ELISA was used to quantify TSST-1 production. Human TSST-1 IgG antibodies were determined from the blood samples using a sandwich ELISA method.

Results: We found only 41% of toxigenic S. aureus and 35.5% of non-toxigenic nasal carriage could be classified as persistent. None of the toxigenic S. aureus vaginal or anal carriage could be classified as persistent. Despite the low persistence of S. aureus colonization, subjects colonized with a toxigenic strain were found to display distributions of antibody titers skewed toward higher titers than other subjects. Seven percent (5/75) of subjects became seropositive during recall, but none experienced toxic shock syndrome-like symptoms.

Conclusions: Nasal carriage of S. aureus appears to be persistent and the best predicator of subsequent colonization, whereas vaginal and anal carriage appear to be more transient. From these findings, it appears that antibody titers in women found to be colonized with toxigenic S. aureus remained skewed toward higher titers whether or not the colonies were found to be persistent or transient in nature. This suggests that colonization at some point in time is sufficient to elevate antibody titer levels and those levels appear to be persistent. Results also indicate that women can become seropositive without experiencing signs or symptoms of toxic shock syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Anti-TSST-1 antibody titers for Groups 1 & 2. A histogram of antibody titers expressed as a two-fold serial dilution starting at 1:4 to ≥ 1024 versus total number of subject visits.
Figure 2
Figure 2
Anti-TSST-1 antibody titers for Groups 3 & 4. A histogram of antibody titers expressed as a two-fold serial dilution starting at 1:4 to ≥ 1024 versus total number of subject visits.

Similar articles

Cited by

References

    1. Chesney PJ. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis. 1989;11(Suppl 1):S1–S7. - PubMed
    1. Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, Harwell J, Lefkowitz LK, Makintubee S, Cundiff DR, Sitze S. the Toxic Shock Syndrome Study Group. Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis. 1989;11(Suppl 1):S28–S34. - PubMed
    1. Todd JK, Wisenthal AM, Ressman M, Caston SA, Hopkins RS. Toxic shock syndrome II. Estimated occurrence in Colorado as influenced by case ascertainment methods. Am J Epidemiol. 1985;122:857–867. - PubMed
    1. Descloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, Mohammedi I, Etienne J. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis. 2008;27(1):37–43. doi: 10.1007/s10096-007-0405-2. - DOI - PubMed
    1. Garbe PL, Arko RL, Reingold AL, Graves LM, Hayes PS, Hightower AW, Chandler FW, Broome CV. Staphylococcus aureus isolates form patients with non-menstrual toxic shock syndrome. Evidence for additional toxins. JAMA. 1985;253:2538. doi: 10.1001/jama.253.17.2538. - DOI - PubMed

Publication types

MeSH terms